There are several reasons why I am not nearly as optimistic about this area of the market as the fourth quarter begins.
Let's see what the charts suggest now.
After a challenging few months, investors are skeptical at start of October. But we remain constructive on stocks into year-end, even with near-term risks.
The chip maker gets a lift from Goldman Sachs' conviction buy list.
Almost there. Third quarter earnings season is practically upon us and will kick off late next week.
Knowing that we are due for a big bounce means buying now, before it happens, rather than waiting for confirmation and missing out on great prices.
Despite the good news of a deal in Congress to avoid a government shutdown, early market indications are weak.
This small-cap is developing a promising new gastrointestinal disease-fighting drug and has one already on the market, making it a great options play.
A concentrated position in the right stock at the right time is how you make exceptional profit. Here are the steps that pro traders employ to rack up huge gains.
Despite a high volume of noise, inflation remains the primary macro driver for markets, while a government shutdown could put the Fed on an automatic 'structural pause.'